https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
In patients with psoriasis, the non-lesional skin also presents abnormalities, requiring emollient application on the whole body. To evaluate the tolerance of a new emollient balm containing celastrol, an active ingredient with anti-Th17 immunomodulatory properties used alone or in association with topical or systemic drug treatments or phototherapy, and its efficacy when used alone. Adults with body plaque psoriasis applied the product over the whole body once a day for 4weeks (balm used alone in 41 patients and with